Faculty profile

Anthony Brade

Back to faculty

Assistant ProfessorDepartment of Radiation OncologyUniversity of Toronto

Anthony Brade

Assistant Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
1 publication in the last five years, latest in 2022.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,407

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE)
JAMA Oncology · 2022
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
European journal of cancer (Oxford, England : 1990) · 2020

All 26 publications

Latest funding

Radiation Therapy and Sorafenib for Primary and Metastatic Liver Cancer
CIHR · 2009 · Co-investigator
$357,495

All 1 grants and awards

26 publications.

Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE)

Louie AV, Granton PV, Fairchild A, Bezjak A, Gopaul D, Mulroy L, Brade A, Warner A, Debenham B, Bowes D

JAMA Oncology202225 citationsOpen Access

DOI: 10.1001/jamaoncol.2021.7664

Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.

Munoz-Schuffenegger P, Barry A, Atenafu EG, Kim J, Brierley J, Ringash J, Brade A, Dinniwell R, Wong RKS, Cho C, Kim TK, Sapisochin G, Dawson LA

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology202143 citations

DOI: 10.1016/j.radonc.2020.11.033 PMID: 33285195

Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.

Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA

European journal of cancer (Oxford, England : 1990)202077 citationsOpen Access

DOI: 10.1016/j.ejca.2020.04.024 PMID: 32460180

Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer

Melosky B, Cheema PK, Brade A, McLeod D, Liu G, Price PW, Jao K, Schellenberg DD, Juergens R, Leighl N

Oncologist202037 citationsOpen Access

DOI: 10.1634/theoncologist.2020-0193

Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer

Melosky B, Juergens R, McLeod D, Leighl N, Brade A, Card PB, Chu Q

Lung Cancer201936 citations

DOI: 10.1016/j.lungcan.2019.05.027

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).

Glick D, Lyen S, Kandel S, Shapera S, Le LW, Lindsay P, Wong O, Bezjak A, Brade A, Cho BCJ, Hope A, Sun A, Giuliani M

Clinical lung cancer201880 citations

DOI: 10.1016/j.cllc.2017.06.021 PMID: 29066051

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.

Loveday BPT, Knox JJ, Dawson LA, Metser U, Brade A, Horgan AM, Gallinger S, Greig PD, Moulton CA

Journal of surgical oncology201855 citations

DOI: 10.1002/jso.24833 PMID: 29480952

The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy

Hosni A, Han K, Le LW, Ringash J, Brierley J, Wong R, Dinniwell R, Brade A, Dawson LA, Cummings BJ

Oncotarget201828 citationsOpen Access

DOI: 10.18632/oncotarget.24926

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

Velec M, Haddad CR, Craig T, Wang L, Lindsay P, Brierley J, Brade A, Ringash J, Wong R, Kim J, Dawson LA

International journal of radiation oncology, biology, physics2017122 citations

DOI: 10.1016/j.ijrobp.2017.01.221 PMID: 28333016

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.

Reiss KA, Herman JM, Armstrong D, Zahurak M, Fyles A, Brade A, Milosevic M, Dawson LA, Scardina A, Fischer P, Hacker-Prietz A, Kinders RJ, Wang L, Chen A, Temkin S, Horiba N, Stayner LA, Siu LL, Azad NS

Gynecologic oncology201754 citationsOpen Access

DOI: 10.1016/j.ygyno.2017.01.016 PMID: 28109627

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Anthony Brade

Research

Latest papers

Latest funding

Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE)

Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.

Long term outcomes of stereotactic body radiation therapy&#xa0;for hepatocellular carcinoma&#xa0;without macrovascular invasion.

Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer

Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.

The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.

Radiation Therapy and Sorafenib for Primary and Metastatic Liver Cancer

Frequent collaborators

Andrea Bezjak

Laura Dawson

Andrew Hope

Jolie Ringash

Alexander Sun

John Kim

James Brierley

John Cho

Meredith Giuliani

Natasha Leighl

Rebecca Wong

Patricia Lindsay

Lisa Wang

Mojgan Taremi

Charles Cho

Rosalyn Juergens

Geoffrey Liu

Michael Milosevic

Lillian Siu

Robert MacRae

Neill Iscoe

Jean-Pierre Bissonnette

Hany Soliman

Ali Hosni

Winnie Li

Anthony Fyles

Jennifer Knox

Bernard Cummings

Najib Safieddine

Andrew Pierre

Carol-Anne Moulton

Sonja Kandel

Ur Metser

Camilla Zimmermann

John Goffin

Caroline Chung

Monika Krzyzanowska

David Hwang

Marc de Perrot

David Hedley

Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.